These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 11876401)

  • 1. Expressions of p53, proliferating cell nuclear antigen, and Ki-67 in gestational trophoblastic diseases.
    Uzunlar AK; Yilmaz F; Bayhan G; Akkuş Z
    Eur J Gynaecol Oncol; 2002; 23(1):79-83. PubMed ID: 11876401
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressions of proliferation markers (Ki-67, proliferating cell nuclear antigen, and silver-staining nucleolar organizer regions) and of p53 tumor protein in gestational trophoblastic disease.
    Kale A; Söylemez F; Ensari A
    Am J Obstet Gynecol; 2001 Mar; 184(4):567-74. PubMed ID: 11262454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical staining properties of PCNA, Ki-67, p53, beta-hCG and HPL in trophoblastic disease.
    Ozbilim G; Karaburun SP; Zorlu G; Kaya R; Erdoğan G; Karaveli S
    Eur J Gynaecol Oncol; 2000; 21(2):200-4. PubMed ID: 10843487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell proliferative activity and mutation of P53 suppressor gene in human gestational trophoblastic disease.
    Persaud V; Ganjei P; Nadji M
    West Indian Med J; 1993 Dec; 42(4):142-3. PubMed ID: 7909185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. P63 expression in hydropic abortion and gestational trophoblastic diseases.
    Ramalho LN; Maggiori MS; Ribeiro-Silva A; Peres LC
    Placenta; 2006; 27(6-7):740-3. PubMed ID: 16026831
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proliferation cell nuclear antigen immunoreactivity for distinguishing hydropic abortions from partial hydatidiform moles.
    Suresh UR; Hale RJ; Fox H; Buckley CH
    J Clin Pathol; 1993 Jan; 46(1):48-50. PubMed ID: 8094402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunohistochemical analysis of c-erbB-2, Bcl-2, p53, p21
    Missaoui N; Landolsi H; Mestiri S; Essakly A; Abdessayed N; Hmissa S; Mokni M; Yacoubi MT
    Pathol Res Pract; 2019 Mar; 215(3):446-452. PubMed ID: 30558966
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The significance of proliferating cell nuclear antigen in human trophoblastic disease: an immunohistochemical study.
    Cheung AN; Ngan HY; Chen WZ; Loke SL; Collins RJ
    Histopathology; 1993 Jun; 22(6):565-8. PubMed ID: 8102616
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferative activity in placentas with hydropic change and hydatidiform mole as detected by Ki-67 and proliferating cell nuclear antigen immunostaining.
    Ostrzega N; Phillipson J; Liu P
    Am J Clin Pathol; 1998 Dec; 110(6):776-81. PubMed ID: 9844590
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of cyclin E in placentas with hydropic change and gestational trophoblastic diseases: implications for the malignant transformation of trophoblasts.
    Kim YT; Cho NH; Ko JH; Yang WI; Kim JW; Choi EK; Lee SH
    Cancer; 2000 Aug; 89(3):673-9. PubMed ID: 10931468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 PCNA, and Ki-67 in hydropic molar and nonmolar placentas: an immunohistochemical study.
    Schammel DP; Bocklage T
    Int J Gynecol Pathol; 1996 Apr; 15(2):158-66. PubMed ID: 8786206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of villous trophoblast proliferation rate in hydatidiform mole and non-molar abortion by assessment of proliferating cell nuclear antigen expression.
    Jeffers MD; Grehan D; Gillan JE
    Placenta; 1994 Jul; 15(5):551-6. PubMed ID: 7997454
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immunohistochemical expression of cell cycle proteins E2F-1, Cdk-2, Cyclin E, p27(kip1), and Ki-67 in normal placenta and gestational trophoblastic disease.
    Olvera M; Harris S; Amezcua CA; McCourty A; Rezk S; Koo C; Felix JC; Brynes RK
    Mod Pathol; 2001 Oct; 14(10):1036-42. PubMed ID: 11598175
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trophoblastic disease: a bridge between pregnancy and malignancy.
    Deligdisch L
    Prog Clin Biol Res; 1981; 70():323-37. PubMed ID: 6171832
    [No Abstract]   [Full Text] [Related]  

  • 15. The relationship between expression of c-ras, c-erbB-2, nm23, and p53 gene products and development of trophoblastic tumor and their predictive significance for the malignant transformation of complete hydatidiform mole.
    Yang X; Zhang Z; Jia C; Li J; Yin L; Jiang S
    Gynecol Oncol; 2002 Jun; 85(3):438-44. PubMed ID: 12051871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p21WAF1/CIP1 expression in gestational trophoblastic disease: correlation with clinicopathological parameters, and Ki67 and p53 gene expression.
    Cheung AN; Shen DH; Khoo US; Wong LC; Ngan HY
    J Clin Pathol; 1998 Feb; 51(2):159-62. PubMed ID: 9602692
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Immunohistochemistry of p57 and p53 protein in differential diagnosis of hydropic abortion, partial and complete hydatidiform mole].
    Chen YX; Shen DH; Gu YQ; Zhong PP; Xie JL; Song QJ; Zhang YL; Wen J
    Zhonghua Bing Li Xue Za Zhi; 2011 Oct; 40(10):694-7. PubMed ID: 22321550
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pathology of gestational trophoblastic diseases.
    Cheung AN
    Best Pract Res Clin Obstet Gynaecol; 2003 Dec; 17(6):849-68. PubMed ID: 14614885
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Histological differential diagnosis of hydatidiform moles and hydropic abortions].
    Zavadil M; Feyereisl J; Hejda V; Krofta L; Safár P
    Cesk Patol; 2009 Jan; 45(1):3-8. PubMed ID: 19402314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of cell proliferation in hydatidiform mole using monoclonal antibody MIB1 to Ki-67 antigen.
    Cheung AN; Ngan HY; Collins RJ; Wong YL
    J Clin Pathol; 1994 Jul; 47(7):601-4. PubMed ID: 8089214
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.